Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome

Author:

Bicknell Brian1,Liebert Ann123,Borody Thomas4,Herkes Geoffrey3ORCID,McLachlan Craig5ORCID,Kiat Hosen1567ORCID

Affiliation:

1. NICM Health Research Institute, University of Western Sydney, Westmead, NSW 2145, Australia

2. Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2006, Australia

3. Department of Governance and Research, Sydney Adventist Hospital, Wahroonga, NSW 2076, Australia

4. Centre for Digestive Diseases, Five Dock, NSW 2046, Australia

5. Centre for Healthy Futures, Torrens University Australia, Ultimo, NSW 2007, Australia

6. Macquarie Medical School, Macquarie University, Macquarie Park, NSW 2109, Australia

7. ANU College of Health and Medicine, Australian National University, Canberra, ACT 2601, Australia

Abstract

The human gut microbiome contains the largest number of bacteria in the body and has the potential to greatly influence metabolism, not only locally but also systemically. There is an established link between a healthy, balanced, and diverse microbiome and overall health. When the gut microbiome becomes unbalanced (dysbiosis) through dietary changes, medication use, lifestyle choices, environmental factors, and ageing, this has a profound effect on our health and is linked to many diseases, including lifestyle diseases, metabolic diseases, inflammatory diseases, and neurological diseases. While this link in humans is largely an association of dysbiosis with disease, in animal models, a causative link can be demonstrated. The link between the gut and the brain is particularly important in maintaining brain health, with a strong association between dysbiosis in the gut and neurodegenerative and neurodevelopmental diseases. This link suggests not only that the gut microbiota composition can be used to make an early diagnosis of neurodegenerative and neurodevelopmental diseases but also that modifying the gut microbiome to influence the microbiome–gut–brain axis might present a therapeutic target for diseases that have proved intractable, with the aim of altering the trajectory of neurodegenerative and neurodevelopmental diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, autism spectrum disorder, and attention-deficit hyperactivity disorder, among others. There is also a microbiome–gut–brain link to other potentially reversible neurological diseases, such as migraine, post-operative cognitive dysfunction, and long COVID, which might be considered models of therapy for neurodegenerative disease. The role of traditional methods in altering the microbiome, as well as newer, more novel treatments such as faecal microbiome transplants and photobiomodulation, are discussed.

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference511 articles.

1. The prenatal gut microbiome: Are we colonized with bacteria in utero?;Walker;Pediatr. Obes.,2017

2. Intrahepatic microbes govern liver immunity by programming NKT cells;Leinwand;J. Clin. Investig.,2022

3. The Healthy Human Blood Microbiome: Fact or Fiction?;Castillo;Front. Cell. Infect. Microbiol.,2019

4. Is there a brain microbiome?;Link;Neurosci. Insights,2021

5. The microbiome as a human organ;Baquero;Clin. Microbiol. Infect.,2012

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Health equity, care access and quality in headache – part 1;The Journal of Headache and Pain;2024-01-29

2. Photobiomodulation for Neurodegenerative Diseases: A Scoping Review;International Journal of Molecular Sciences;2024-01-28

3. Parkinson’s Disease and Photobiomodulation: Potential for Treatment;Journal of Personalized Medicine;2024-01-19

4. Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies;Experimental & Molecular Medicine;2024-01-04

5. Migraine Comorbidities;Life;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3